Azin Parhizgar

Azin is a highly accomplished medical device executive and serial entrepreneur. She has served as an advisor and board member to numerous emerging medtech companies as well as various academic boards. Currently Dr. Parhizgar is a senior Venture Partner at 415 Capital Management, a cardiovascular focused early-stage venture investment fund, Chairman of the board of CVPath Institute, Inc. and serves as a director at SoundBite Medical Inc., among other held positions. In her five-year tenure as the President and CEO of Claret Medical, an embolic protection company, Dr. Parhizgar led the venture-backed company to a successful global commercial launch with a subsequent acquisition in 2018 by Boston Scientific, Inc. Prior to Claret Medical, she was the COO of Conor Medsystems, a drug-eluting Stent Company acquired by Johnson & Johnson, Inc. in 2007. Following Conor Medsystem’s acquisition, she remained with J&J for the following year to support the full integration of the company. Prior to Conor Medsystems Dr. Parhizgar was Senior Vice President at Arterial Vascular Engineering (AVE), which was acquired by Medtronic Inc. in 2000. She remained with Medtronic for the following two years as Executive Vice President of Emerging Ventures and New Technologies leading key investments in early stage companies for Medtronic Vascular division. Dr. Parhizgar earned both her Ph.D. in Cell, Gene and Tissue Engineering and her M.Sc. in Biomechanical Engineering and Artificial Organ Design from Brown University in Providence, RI, USA.